Temsirolimus in patients with renal cancer on hemodialysis.
Lunardi
Gianluigi
G
Vannozzi
Maria Ornella
MO
Armirotti
Andrea
A
Nicodemo
Maurizio
M
Venturini
Marco
M
Cavallini
Lucia
L
D000284:Administration, Oral; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D019540:Area Under Curve; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary* / Q000601:surgery; D018450:Disease Progression; D004334:Drug Administration Schedule; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy; D009362:Neoplasm Metastasis; D006435:Renal Dialysis; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D013997:Time Factors; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; C401859:temsirolimus; D020123:Sirolimus